» Articles » PMID: 23894603

Population-based CD4 Counts in a Rural Area in South Africa with High HIV Prevalence and High Antiretroviral Treatment Coverage

Overview
Journal PLoS One
Date 2013 Jul 30
PMID 23894603
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Little is known about the variability of CD4 counts in the general population of sub-Saharan Africa countries affected by the HIV epidemic. We investigated factors associated with CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment (ART) coverage.

Methods: CD4 counts, health status, body mass index (BMI), demographic characteristics and HIV status were assessed in 4990 adult resident participants of a demographic surveillance in rural KwaZulu-Natal in South Africa; antiretroviral treatment duration was obtained from a linked clinical database. Multivariable regression analysis, overall and stratified by HIV status, was performed with CD4 count levels as outcome.

Results: Median CD4 counts were significantly higher in women than in men overall (714 vs. 630 cells/µl, p<0.0001), both in HIV-uninfected (833 vs. 683 cells/µl, p<0.0001) and HIV-infected adults (384.5 vs. 333 cells/µl, p<0.0001). In multivariable regression analysis, women had 19.4% (95% confidence interval (CI) 16.1-22.9) higher CD4 counts than men, controlling for age, HIV status, urban/rural residence, household wealth, education, BMI, self-reported tuberculosis, high blood pressure, other chronic illnesses and sample processing delay. At ART initiation, HIV-infected adults had 21.7% (95% CI 14.6-28.2) lower CD4 counts than treatment-naive individuals; CD4 counts were estimated to increase by 9.2% (95% CI 6.2-12.4) per year of treatment.

Conclusions: CD4 counts are primarily determined by sex in HIV-uninfected adults, and by sex, age and duration of antiretroviral treatment in HIV-infected adults. Lower CD4 counts at ART initiation in men could be a consequence of lower CD4 cell counts before HIV acquisition.

Citing Articles

Estimating the burden of mpox among MSM in South Africa.

McCabe R, Johnson L, Whittles L BMJ Glob Health. 2025; 10(2).

PMID: 39971582 PMC: 11840921. DOI: 10.1136/bmjgh-2024-017268.


Hypertension in people living with HIV on combined antiretroviral therapy in rural Tanzania.

Trifiro S, Cavallin F, Mangi S, Mhaluka L, Maffoni S, Taddei S Afr Health Sci. 2023; 23(1):129-136.

PMID: 37545920 PMC: 10398461. DOI: 10.4314/ahs.v23i1.15.


Point of Care CD4 Testing in National Household Surveys - Results and Quality Indicators from Eleven Population-Based HIV Impact Assessment (PHIA) Surveys.

Birhanu S, Winterhalter F, Stupp P, Cates M, Rottinghaus E, Yavo D Microbiol Spectr. 2023; 11(3):e0314822.

PMID: 37071009 PMC: 10269725. DOI: 10.1128/spectrum.03148-22.


Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019.

Serwin K, Urbanska A, Scheibe K, Witak-Jedra M, Jankowska M, Hlebowicz M Sci Rep. 2021; 11(1):16609.

PMID: 34400726 PMC: 8367969. DOI: 10.1038/s41598-021-96125-w.


Effect of Traditional Chinese Medicine Therapy on the Trend in CD4 T-Cell Counts among Patients with HIV/AIDS Treated with Antiretroviral Therapy: A Retrospective Cohort Study.

Wang D, Ma S, Ma Y, Guo H, Li P, Yang C Evid Based Complement Alternat Med. 2021; 2021:5576612.

PMID: 34326884 PMC: 8302365. DOI: 10.1155/2021/5576612.


References
1.
Abuye C, Tsegaye A, West C, Versloot P, Sanders E, Wolday D . Determinants of CD4 counts among HIV-negative Ethiopians: role of body mass index, gender, cigarette smoking, khat (Catha Edulis) chewing, and possibly altitude?. J Clin Immunol. 2005; 25(2):127-33. DOI: 10.1007/s10875-005-2818-y. View

2.
Mandala W, MacLennan J, Gondwe E, Ward S, Molyneux M, MacLennan C . Lymphocyte subsets in healthy Malawians: implications for immunologic assessment of HIV infection in Africa. J Allergy Clin Immunol. 2009; 125(1):203-8. PMC: 2887487. DOI: 10.1016/j.jaci.2009.10.010. View

3.
Lawn S, Myer L, Edwards D, Bekker L, Wood R . Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009; 23(13):1717-25. PMC: 3801095. DOI: 10.1097/QAD.0b013e32832d3b6d. View

4.
Oladepo D, Idigbe E, Audu R, Inyang U, Imade G, Philip A . Establishment of reference values of CD4 and CD8 lymphocyte subsets in healthy Nigerian adults. Clin Vaccine Immunol. 2009; 16(9):1374-7. PMC: 2745013. DOI: 10.1128/CVI.00378-08. View

5.
Zeh C, Amornkul P, Inzaule S, Ondoa P, Oyaro B, Mwaengo D . Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya. PLoS One. 2011; 6(6):e21040. PMC: 3119664. DOI: 10.1371/journal.pone.0021040. View